Ensysce Biosciences Inc (ENSC): about time special meeting (the “spec...

Reply Private New

Next 10 Prev Next

Send PM Follow Ignore

Followers	8
Posts	1686
Boards Moderated	0
Alias Born	02/16/2011

Skeptical

Re: None

Tuesday, 06/15/2021 8:14:40 AM

Tuesday, June 15, 2021 8:14:40 AM

about time

special meeting (the “special meeting”) of stockholders to be held at 9:00 a.m. eastern time, on June 28, 2021, at the offices of LACQ at 250 West 57th Street, Suite 415, New York, New York 10107

Keep Last Read

Next 10 Prev Next

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:

Detailed Quote

Recent ENSC News

Form 424B3 - Prospectus [Rule 424(b)(3)] • Edgar (US Regulatory) • 02/15/2024 05:19:52 PM
Form 8-K - Current report • Edgar (US Regulatory) • 02/14/2024 10:27:47 PM
Form 424B3 - Prospectus [Rule 424(b)(3)] • Edgar (US Regulatory) • 02/14/2024 11:05:44 AM
Biotech Soars On FDA Announcement • AllPennyStocks.com • 01/23/2024 08:45:00 PM
Form S-1 - General form for registration of securities under the Securities Act of 1933 • Edgar (US Regulatory) • 01/17/2024 02:56:45 AM
Form 8-K - Current report • Edgar (US Regulatory) • 12/29/2023 09:15:30 PM
Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material • Edgar (US Regulatory) • 12/19/2023 09:27:20 PM
Form 8-K - Current report • Edgar (US Regulatory) • 12/19/2023 09:24:52 PM
Form RW - Registration Withdrawal Request • Edgar (US Regulatory) • 11/30/2023 07:37:39 PM
Form 8-K - Current report • Edgar (US Regulatory) • 11/29/2023 02:24:43 PM
Form EFFECT - Notice of Effectiveness • Edgar (US Regulatory) • 11/22/2023 05:15:07 AM
Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend] • Edgar (US Regulatory) • 11/17/2023 10:19:34 PM
Form 8-K - Current report • Edgar (US Regulatory) • 11/17/2023 09:15:40 PM
Form S-1 - General form for registration of securities under the Securities Act of 1933 • Edgar (US Regulatory) • 11/09/2023 10:06:54 PM
Form 8-K - Current report • Edgar (US Regulatory) • 11/09/2023 10:02:56 PM
Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 11/09/2023 09:56:33 PM
Form PRE 14A - Other preliminary proxy statements • Edgar (US Regulatory) • 10/30/2023 09:04:31 PM
Form 8-K - Current report • Edgar (US Regulatory) • 10/24/2023 11:59:13 AM
Form 8-K - Current report • Edgar (US Regulatory) • 08/28/2023 09:20:56 PM
Form 8-K - Current report • Edgar (US Regulatory) • 08/11/2023 12:10:24 PM

More ENSC News

InvestorsHub NewsWire

NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • NNVC • May 2, 2024 10:07 AM

ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM

Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM

Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM

Cannabix Technologies to Deliver Breath Logix Alcohol Screening Device to Australia • BLO • Apr 30, 2024 8:53 AM

Hydromer, Inc. Reports Preliminary Unaudited Financial Results for First Quarter 2024 • HYDI • Apr 29, 2024 9:10 AM

Start posting your company's news

Only $200 per official company press release!

Volume
Day Range:
Bid Price
Ask Price
Last Trade Time:

Boards:

Quotes:

Boards

News

Market Data

Markets

Discover